Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Peptide Drug Conjugates Market to reach USD 2330.96 million by the end of 2029.

Global Peptide Drug Conjugates Market Size study & Forecast, by Product (Lutetium, Melflufen, ANG1005, BT1718, CBX-12, Other Pipeline Products) by Type (Therapeutic, Diagnostic) and Regional Analysis, 2022-2029

Product Code: HLSDT-47479155
Publish Date: 25-01-2023
Page: 200

Global Peptide Drug Conjugates Market is valued at approximately USD 596.27 million in 2021 and is anticipated to grow with a healthy growth rate of more than 18.58% over the forecast period 2022-2029. Peptide–drug conjugates are organic molecules composed of a small drug molecule, a peptide, and a linker. The drug molecule is necessary for the biological activity aids in targeted administration and helps in the enhance the effectiveness of treatment and frequently minimizing undesirable side effects. The increasing expenditure on clinical trial, favorable reimbursement policies, coupled with the rising expenditure on the development of the healthcare facilities are the primary factors that are attributing towards the market growth around the world.

The rising incidences of cancer and related mortality is fueling the demand for peptide drug conjugates for the treatment of the target diseases. The National Cancer Institute, the number of cancer patients is projected to rise to 29.5 million cases by the year 2040 from 18.1 million cases in the year 2018. Accordingly, as per the National Cancer Institute, there are more than 250 FDA approved chemotherapeutic drugs used in the treatment of malignant tumors. Thus, these aforementioned factors are exhibiting a positive influence on the growth of the market. Moreover, a strong product pipeline, as well as the growing R&D investment are presenting various lucrative opportunities over the forecasting years. However, the slow clinical development process and major drawback associated with such small molecules are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Peptide Drug Conjugates Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness about availability of treatment options, along with the rising government initiatives and favorable reimbursement policies. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing incidences of cancer and related mortality, as well as growing investments to develop and commercialize such novel delivery systems in the market space.

Major market players included in this report are:
Novartis AG
Oncopeptides AB
Bicycle Therapeutics
Cybrexa Therapeutics
Angiochem Inc.
Innovasium Soricimed Biopharma
Pfizer Inc.
Validus Pharmaceuticals LLC

Recent Developments in the Market:
 In November 2022, Cybrexa Therapeutics and Exelixis, Inc. unveiled the company collaborative agreement to offer Exelixis the right to acquire, first-in-class peptide-drug conjugate (PDC), CBX-12. The main objective of this initiative is likely to expand its clinical pipeline for the targeted drug therapy.
 In June 2019, Novartis AG and PeptiDream Inc. entered a strategic collaboration in order to develop PDC, macrocyclic peptide for diagnostic and therapeutic applications.

Global Peptide Drug Conjugates Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Other Pipeline Products
By Type:

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Peptide Drug Conjugates Market, by Region, 2019-2029 (USD Million)
1.2.2. Peptide Drug Conjugates Market, by Product, 2019-2029 (USD Million)
1.2.3. Peptide Drug Conjugates Market, by Type, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Peptide Drug Conjugates Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Peptide Drug Conjugates Market Dynamics
3.1. Peptide Drug Conjugates Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Rising incidences of cancer and related mortality Increasing expenditure on clinical trial
3.1.2. Market Challenges Slow clinical development process Major drawback associated with such small molecules
3.1.3. Market Opportunities Strong product pipeline Growing R&D investment
Chapter 4. Global Peptide Drug Conjugates Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Peptide Drug Conjugates Market, by Product
6.1. Market Snapshot
6.2. Global Peptide Drug Conjugates Market by Product, Performance – Potential Analysis
6.3. Global Peptide Drug Conjugates Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Peptide Drug Conjugates Market, Sub Segment Analysis
6.4.1. Lutetium
6.4.2. Melflufen
6.4.3. ANG1005
6.4.4. BT1718
6.4.5. CBX-12
6.4.6. Other Pipeline Products
Chapter 7. Global Peptide Drug Conjugates Market, by Type
7.1. Market Snapshot
7.2. Global Peptide Drug Conjugates Market by Type, Performance – Potential Analysis
7.3. Global Peptide Drug Conjugates Market Estimates & Forecasts by Type 2019-2029 (USD Million)
7.4. Peptide Drug Conjugates Market, Sub Segment Analysis
7.4.1. Therapeutic
7.4.2. Diagnostic
Chapter 8. Global Peptide Drug Conjugates Market, Regional Analysis
8.1. Peptide Drug Conjugates Market, Regional Market Snapshot
8.2. North America Peptide Drug Conjugates Market
8.2.1. U.S. Peptide Drug Conjugates Market Product breakdown estimates & forecasts, 2019-2029 Type breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Peptide Drug Conjugates Market
8.3. Europe Peptide Drug Conjugates Market Snapshot
8.3.1. U.K. Peptide Drug Conjugates Market
8.3.2. Germany Peptide Drug Conjugates Market
8.3.3. France Peptide Drug Conjugates Market
8.3.4. Spain Peptide Drug Conjugates Market
8.3.5. Italy Peptide Drug Conjugates Market
8.3.6. Rest of Europe Peptide Drug Conjugates Market
8.4. Asia-Pacific Peptide Drug Conjugates Market Snapshot
8.4.1. China Peptide Drug Conjugates Market
8.4.2. India Peptide Drug Conjugates Market
8.4.3. Japan Peptide Drug Conjugates Market
8.4.4. Australia Peptide Drug Conjugates Market
8.4.5. South Korea Peptide Drug Conjugates Market
8.4.6. Rest of Asia Pacific Peptide Drug Conjugates Market
8.5. Latin America Peptide Drug Conjugates Market Snapshot
8.5.1. Brazil Peptide Drug Conjugates Market
8.5.2. Mexico Peptide Drug Conjugates Market
8.5.3. Rest of Latin America Peptide Drug Conjugates Market
8.6. Rest of The World Peptide Drug Conjugates Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Novartis AG Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.2.2. Oncopeptides AB
9.2.3. Bicycle Therapeutics
9.2.4. AstraZeneca
9.2.5. Cybrexa Therapeutics
9.2.6. Angiochem Inc.
9.2.7. Innovasium Soricimed Biopharma
9.2.8. Theratechnologies
9.2.9. Pfizer Inc.
9.2.10. Validus Pharmaceuticals LLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now